指南与共识瓣膜病与结构性心脏病

ESC/EACTS与ACC/AHA重度主动脉瓣狭窄管理指南对比

ESC/EACTS vs. ACC/AHA guidelines for the management of severe aortic stenosis.
指南 / 共识 · Eur Heart J · 2023-01-01

本综述对比2021年ESC/EACTS与2020年ACC/AHA重度主动脉瓣狭窄指南,基于现有证据分析推荐异同。两者总体一致,但在无症状患者干预时机(LVEF 55% vs 60%)、外科生物瓣年龄阈值(≥65岁 vs 多年龄类别)及TAVR与SAVR年龄切点三方面存在关键差异。

要点

  • 无症状重度AS干预LVEF阈值:欧洲55%,美国60%(连续影像)。
  • 外科生物瓣年龄阈值:欧洲≥65岁,美国采用多年龄类别。
  • TAVR与SAVR年龄切点两指南不同,证据有限。

核心结论

  • 欧美指南对重度AS管理总体一致,但干预时机、瓣膜选择和TAVR与SAVR标准三方面存在分歧。

研究设计与样本

  • 本综述为现状综述,对比2021年ESC/EACTS指南与2020年ACC/AHA指南的推荐及证据。

主要发现

  • 欧洲指南推荐无症状患者LVEF 55%时干预,美国指南推荐连续影像LVEF 60%时干预。
  • 欧洲指南推荐外科生物瓣年龄阈值≥65岁,美国指南采用多年龄类别以考虑患者因素和偏好。
  • 两指南对TAVR与SAVR的年龄切点不同,尽管证据有限。
  • 综述还讨论了机械瓣置换比例下降的趋势。

关键数值与推荐

  • 无症状患者干预LVEF阈值:欧洲55%,美国60%(连续影像)。
  • 外科生物瓣年龄阈值:欧洲≥65岁;美国多年龄类别。
  • TAVR与SAVR年龄切点:两指南不同,证据有限。

临床怎么用

  • 临床决策应结合指南差异,个体化评估无症状患者干预时机、瓣膜类型及TAVR与SAVR选择。

局限性

  • 证据缺口包括无症状患者TAVI、Ross手术适宜性、主动脉瓣置换同期冠脉血运重建及二叶式AS。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Aortic stenosis (AS) is a serious and complex condition, for which optimal management continues to evolve rapidly. An understanding of current clinical practice guidelines is critical to effective patient care and shared decision-making. This state of the art review of the 2021 European Society of Cardiology/European Association for Cardio-Thoracic Surgery Guidelines and 2020 American College of Cardiology/American Heart Association Guidelines compares their recommendations for AS based on the evidence to date. The European and American guidelines were generally congruent with the exception of three key distinctions. First, the European guidelines recommend intervening at a left ventricular ejection fraction of 55%, compared with 60% over serial imaging by the American guidelines for asymptomatic patients. Second, the European guidelines recommend a threshold of ≥65 years for surgical bioprosthesis, whereas the American guidelines employ multiple age categories, providing latitude for patient factors and preferences. Third, the guidelines endorse different age cut-offs for transcatheter vs. surgical aortic valve replacement, despite limited evidence. This review also discusses trends indicating a decreasing proportion of mechanical valve replacements. Finally, the review identifies gaps in the literature for areas including transcatheter aortic valve implantation in asymptomatic patients, the appropriateness of Ross procedures, concomitant coronary revascularization with aortic valve replacement, and bicuspid AS. To summarize, this state of the art review compares the latest European and American guidelines on the management of AS to highlight three areas of divergence: timing of intervention, valve selection, and surgical vs. transcatheter aortic valve replacement criteria.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Lee G, Chikwe J, Milojevic M, et al. ESC/EACTS vs. ACC/AHA guidelines for the management of severe aortic stenosis. Eur Heart J. 2023. PMID: 36632841. doi:10.1093/eurheartj/ehac803

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。